1. Home
  2. AVXL vs SAR Comparison

AVXL vs SAR Comparison

Compare AVXL & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$4.49

Market Cap

388.7M

Sector

Health Care

ML Signal

HOLD

Logo Saratoga Investment Corp New

SAR

Saratoga Investment Corp New

HOLD

Current Price

$23.46

Market Cap

372.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVXL
SAR
Founded
2004
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
388.7M
372.7M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
AVXL
SAR
Price
$4.49
$23.46
Analyst Decision
Strong Buy
Hold
Analyst Count
3
4
Target Price
$22.00
$23.75
AVG Volume (30 Days)
1.2M
122.6K
Earning Date
04-27-2026
01-01-0001
Dividend Yield
N/A
13.82%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.39
P/E Ratio
N/A
$9.44
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$21.10
52 Week High
$13.99
$26.17

Technical Indicators

Market Signals
Indicator
AVXL
SAR
Relative Strength Index (RSI) 55.96 52.58
Support Level $3.60 $22.39
Resistance Level $4.88 $23.72
Average True Range (ATR) 0.27 0.49
MACD 0.05 -0.00
Stochastic Oscillator 78.01 71.15

Price Performance

Historical Comparison
AVXL
SAR

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

Share on Social Networks: